Population-Based Outcome of Stage IA-IIA Resected Gastric Adenocarcinoma: Who Should Get Adjuvant Treatment?

Background The benefit of adjuvant treatment in gastric adenocarcinoma was demonstrated by randomized, controlled trials of patients with locally advanced tumors. Thus, its role for stage IIB-IIIC disease is widely accepted. We aimed to identify patients with stage IA-IIA gastric adenocarcinoma who...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of surgical oncology 2013-07, Vol.20 (7), p.2304-2310
Hauptverfasser:	Gold, Jason S., Al Natour, Riad H., Saund, Mandeep S., Yoon, Charles, Sharma, Ashish M., Huang, Qin, Boosalis, Valia A., Whang, Edward E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - pathology Adenocarcinoma - therapy Adolescent Adult Age Factors Aged Aged, 80 and over Combined Modality Therapy Female Gastrectomy Gastrointestinal Oncology Humans Kaplan-Meier Estimate Male Medicine Medicine & Public Health Middle Aged Neoplasm Grading Neoplasm Staging Oncology Proportional Hazards Models Risk Assessment SEER Program Stomach Neoplasms - pathology Stomach Neoplasms - therapy Surgery Surgical Oncology Survival Rate Tumor Burden Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!